NorthWest Biotherapeutics Inc (NWBO)

[AVII77]

If what you suggest were the case, that an official IA took place in the summer of 2015, and as a result, the DMC gave an official recommendation that the trial be halted for futility, and the company refused to comply with the recommendation... and so the FDA forced the screening halt to ensure no one new (except those in the pipeline for which vaccines were already made) entered the trial, why then would the FDA lift the screening halt in Feb 2017?

For the same reason the FDA lifted the partial hold on Cel-Sci after futility: because the sponsor agreed to not enroll additional patients.

Senti, how would you feel if someone you loved and was stricken by a deadly disease was told they could contribute to science by participating in a trial testing if Drug X improved PFS ...... after the trialists know they have a low liklihood of answering that question.

Don't you think that's a detail a patient considering participating in a trial should know?